
    
      Participants will be screened for up to 28 days prior to first investigational product
      administration. Eligible participants will be admitted to the clinical unit on day -1 and
      will be residential for a single period of 17 days/16 nights.

      Participants will be discharged from the clinical unit on day 16 on the condition that all
      required assessments have been performed and that there are no medical reasons for a longer
      stay in the clinical unit.
    
  